Daily Market Commentary : Nifty ends flat at 25,212, up 16 pts after early losses by Says Mr. Siddhartha Khemka, Motilal Oswal
Below the Quote on Daily market commentary by Mr. Siddhartha Khemka, Head - Research, Wealth Management, Motilal Oswal Financial Services Ltd
Indian equities recouped early losses to end flat on Tuesday, with the Nifty50 closing at 25,212, up 16 points or 0.06%. Broader markets were largely unchanged, with the Nifty Midcap100 and Smallcap100 indices ending marginally lower by 0.01% and 0.03%, respectively. In a largely range-bound session, PSU bank stocks stood out, with the Nifty PSU Bank index rising 1.8% on reports that the government may consider a fresh round of financial sector reforms. On the flip side, Nifty Metals declined 0.5%, tracking strength in the US dollar amid elevated US inflation readings. Pharma stocks were supported by positive industry data. The India Pharma Market grew 11.5% YoY in June, led by strong performance in acute therapies. Acute therapy growth rebounded to 11% in June (vs. 5% in May), aided by seasonal trends and a revival in anti-infectives. Over the past 6–9 months, rural demand has seen a notable revival, outpacing urban consumption. This recovery follows nearly two years of softness due to high inflation, weak savings, and sluggish tractor sales. With easing inflation, policy support, and favorable weather, rural markets appear well-positioned for a steady and inclusive rebound. Both FIIs and DIIs were net buyers on Tuesday, cushioning broader weakness as investors remained cautious amid renewed US tariff talks and a lacklustre start to the Q1 earnings season. Key global macro releases due on Thursday includes EUR CPI, UK unemployment, and US retail sales and jobless claims. Q1 results due tomorrow include Axis Bank, Wipro, Jio Financial, LTI Mindtree, HDFC AMC, Indian Hotels, among others. We expect markets to consolidate with a positive bias, supported improving rural and healthcare trends, and any progress on India–US trade negotiations. Stock-specific action will likely continue as the earnings season gathers pace.
Above views are of the author and not of the website kindly read disclaimer
